Although pfpCTL alone showed a significantly anti-tumor cytotoxicity (p<0.001), combinational therapy of CTLs and TRAIL exhibits significantly greater tumor rejection efficacy against the established colon carcinoma lung metastases than CTL alone (p<0.001)(Fig. 7C). The gene discussed is TNFSF10; the disease is neoplasm.